Skip to main content
. 2020 Sep 26;12(10):922. doi: 10.3390/pharmaceutics12100922

Table 3.

Product classification and routes for the authorization of medical devices within the EU [135].

Class Risk Description Route
I Low risk Non-invasive, does not interact with body Self-declaration route outlines in Annex VII Module. An EU Declaration of Conformity—manufacturer must declare the device satisfies the provisions of the directive.
IIa Medium Generally invasive
Therapeutic transfer of energy to patient or used for the diagnosis or monitoring of medical condition
Carry out conformity assessment carried out by NB using Annex II, IV, V, or VI.
Can declare conformity with the provisions of directives and regulations (Annex VII).
IIb Medium Invasive—surgical or implantation
Potential to modify body fluid
Full quality assurance (Annex II)—with assessment by NB of technical documents in one sample in accordance with the directive (Annex II, Section 7).
III High Invasive—used to sustain human life, essential to maintain human health
Devices connected to CNS or CCS
Full quality assurance system audit (Annex II)—full examination of device by a Notified Body (NB)